Edwards Lifesciences (EW) announced two strategic transactions involving companies with structural heart disease tech
March 11, 2019 8:32 AM
Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
